Impact of plasma xanthine oxidoreductase activity in patients with heart failure with preserved ejection fraction

K Watanabe, T Watanabe, Y Otaki, T Shishido… - ESC heart …, 2020 - Wiley Online Library
Aims Reactive oxygen species are reportedly involved in the mechanism underlying heart
failure with preserved ejection fraction (HFpEF); however, the disease pathophysiology …

Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure

Y Otaki, T Watanabe, D Kinoshita, M Yokoyama… - International journal of …, 2017 - Elsevier
Background Oxidative stress due to purine degradation is associated with the development
of chronic heart failure (CHF). Xanthine oxidoreductase (XOR) is a rate-limiting enzyme of …

Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients

Y Fujimura, Y Yamauchi, T Murase, T Nakamura… - PLoS …, 2017 - journals.plos.org
Background and purpose Xanthine oxidoreductase (XOR), which catalyzes purine
catabolism, has two interconvertible forms, xanthine dehydrogenase and xanthine oxidase …

Plasma xanthine oxidoreductase activity in patients with decompensated acute heart failure requiring intensive care

H Okazaki, A Shirakabe, M Matsushita… - ESC heart …, 2019 - Wiley Online Library
Aims Plasma xanthine oxidoreductase (XOR) activity during the acute phase of acute heart
failure (AHF) requires further elucidation. Methods and results One hundred eighteen AHF …

[HTML][HTML] Prognostic impact of plasma xanthine oxidoreductase activity in patients with heart failure with atrial fibrillation

K Watanabe, T Arimoto, T Watanabe, Y Otaki… - Journal of …, 2023 - Elsevier
Background Xanthine oxidoreductase (XOR) is a rate-limiting enzyme for uric acid (UA)
production and plays an important role in generating reactive oxygen species (ROS) …

Effects of xanthine oxidase inhibition in hyperuricemic heart failure patients: the xanthine oxidase inhibition for hyperuricemic heart failure patients (EXACT-HF) study

MM Givertz, KJ Anstrom, MM Redfield, A Deswal… - Circulation, 2015 - Am Heart Assoc
Background—Oxidative stress may contribute to heart failure (HF) progression. Inhibiting
xanthine oxidase in hyperuricemic HF patients may improve outcomes. Methods and …

The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study

HE Cingolani, JA Plastino, EM Escudero… - Journal of cardiac …, 2006 - Elsevier
BACKGROUND: Reactive oxygen species (ROS) have been linked to hypertrophy,
remodeling and abnormal excitation-contraction coupling. Previous data demonstrated that …

Uric acid and xanthine oxidase in heart failure—Emerging data and therapeutic implications

W Doehner, EA Jankowska, J Springer… - International journal of …, 2016 - Elsevier
The role of hyperuricaemia as cardiovascular risk factor has exhaustingly been debated for
decades. While the association of elevated uric acid (UA) levels with increased mortality risk …

[引用][C] Elevated plasma xanthine oxidase activity in chronic heart failure: Source of increased oxygen radical load and effect of allopurinol in a placebo controlled …

W Doehner, MM Tarpey, DV Pavitt, AP Bolger… - Journal of the American …, 2003 - jacc.org
Background: Elevated xanthine oxidase (X0) activity contributes to production of reactive
oxygen species. Hyperuicemia is common in chronic heart failure (CHF), however, enzyme …

Plasma xanthine oxidoreductase (XOR) activity in cardiovascular disease outpatients

M Matsushita, A Shirakabe, H Okazaki, Y Shibata… - Circulation …, 2020 - jstage.jst.go.jp
Background: The mechanisms of the increased plasma xanthine oxidoreductase (XOR)
activity in outpatients with cardiovascular disease were unclear. Methods and Results: A …